1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends

Analysis of the Cardiac Biomarker Diagnostics Market 

  • September 2015
  • 116 pages
  • Frost & Sullivan
Report ID: 3327250

Summary

Table of Contents

Analysis of the Cardiac Biomarker Diagnostics Market 

Key Findings

The overall US cardiac biomarker diagnostic market stands at $ million in 2014 and is predicted to grow to $ million by 2021 at a compound annual growth rate (CAGR) of %.

- The increasing adoption of point-of-care tests (POCTs) in the United States makes this segment the fastest growing, where it holds close to % of the cardiac biomarker market.

- There is an increasing number of publications discussing the importance of POCT in improving patient outcomes. This is spurring adoption rate at a clinical and ambulatory level.

- The POCT market for cardiac biomarkers is spurring the growth in this region.

- With the implementation of Affordable Care Act (ACA), there is a shift toward value-based care. This is increasing pressure on manufacturers to produce more cost efficient and efficient devices for consumers, especially in the hospital sector.

- Manufacturers are seeing the value of integrated and wholesome platform solutions in this emerging value-based system.

- Device companies like Medtronic are entering the cardiac space to provide telehealth solutions to patients. Siemens and Roche have a unique advantage due to their strong affiliation with their medical devices and pharmaceutical wings, respectively.

- Companies with different diagnostic wings have a unique advantage, as they can offer a more integrated solution to diagnose a patient.

- Still in the early stages, the cardiovascular segment has tremendous potential for personalized medicine. There is a movement toward this space similar to other fields, like oncology.

- In the future, heart failure therapy is going to utilize a combination of multiple markers for risk assessment and diagnosis. Many of these biomarker tests are going to combine into a panel test rather than compete individually.

- Products with a narrow therapeutic index, which can be dangerous either over- or underdosing, have a higher profitability capacity to develop companion diagnostic tests to determine sensitivity to the product.

- Companion diagnostics is a major opportunity for manufacturers as cardiovascular disease holds only % of the overall companion diagnostics market space.

- Integrating digital apps enables manufacturers to understand consumer behavior but also provide differentiated products compared to competitors.

- Manufacturers can begin to offer consultations and services for biomarker testing and not be exclusive to providing lab solutions.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

2017-2021 World Cancer Diagnostics Market: Supplier Shares and Strategies, Country Segment Forecasts, Tehnology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers

  • $ 21100
  • Industry report
  • July 2017
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Global Cancer Diagnostics Market Analysis 2021: USA, Europe, Japan--Supplier Shares and Strategies, Emerging Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation

  • $ 21100
  • Industry report
  • June 2017
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. VPGMarketResearch.com's new report is a study of the major business opportunities emerging in the global cance ...

World Molecular Diagnostic Analyzers and Reagents Market 2021: USA, Europe, Japan--Supplier Shares by Test, Competitive Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 15900
  • Industry report
  • June 2017
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $15,900. This new seven-country study from VPGMarketResearch.com contains 1,398 pages, 194 tables, and is designed to ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.